Adding Medication to Lamotrigine for Bipolar II Depression
For bipolar II disorder patients with persistent depressive symptoms on lamotrigine, add an SSRI (preferably sertraline or escitalopram) or bupropion, always maintaining the lamotrigine as the mood stabilizer foundation. 1, 2
Evidence-Based Medication Options
First-Line: SSRI Addition
Sertraline or escitalopram are the preferred SSRIs because they have minimal CYP450 interactions with lamotrigine and moderate-to-high evidence for efficacy in treating depressive symptoms in bipolar disorder 1, 3.
Dosing algorithm:
- Start sertraline 25mg daily or escitalopram 5mg daily as a test dose for 3-7 days 1
- Increase to sertraline 50mg daily or escitalopram 10mg daily after the test period 1
- Titrate sertraline by 25-50mg every 1-2 weeks to target 100-150mg daily 1
- Titrate escitalopram by 5mg every 2-3 weeks to target 10-20mg daily 1
Alternative: Bupropion
Bupropion XL 150-300mg daily has lower risk of mood destabilization compared to SSRIs and may improve motivation through dopaminergic effects 1. Start at 150mg daily for 3-7 days, then increase to 300mg daily if tolerated 1.
Critical Safety Monitoring
Monitor closely for mood destabilization including increased energy, decreased sleep need, impulsivity, irritability, or treatment-emergent mania at every visit during the first 8 weeks 1, 2.
Watch for behavioral activation (motor restlessness, insomnia, impulsiveness, disinhibited behavior, aggression), which is more common in younger patients and can be difficult to distinguish from mania 1.
Screen for serotonin syndrome within 24-48 hours after starting or increasing SSRI doses, characterized by mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity 1.
Expected Response Timeline
- Initial response should emerge within 2-4 weeks 1
- Maximal benefit occurs by 8-12 weeks 1
- If inadequate response after 8 weeks at therapeutic doses despite good adherence, add cognitive behavioral therapy rather than increasing medication doses further 1, 3
Supporting Evidence for Lamotrigine + Antidepressant
Lamotrigine provides the mood stabilization foundation that prevents antidepressant-induced switching to mania or hypomania 1, 2. Studies in bipolar II depression show that 52% of patients achieved "very much improvement" and 32% were "much improved" when lamotrigine was combined with other psychotropic medications for treatment-resistant depression 4.
Adjunctive lamotrigine specifically for bipolar II depression demonstrated significant reduction in depression severity with large effect size over 52 weeks, with discontinuation rates of only 22.9% among responders 5.
What NOT to Do
Never use antidepressant monotherapy in bipolar disorder—this dramatically increases risk of mood destabilization, mania induction, and rapid cycling 1, 2.
Avoid tricyclic antidepressants as they carry higher risk of mood destabilization compared to SSRIs or bupropion 1.
Do not add buspirone for depression augmentation—the STAR*D trial showed significantly higher discontinuation rates (20.6%) with buspirone compared to bupropion (12.5%), and buspirone provided no therapeutic advantage for comorbid anxiety in bipolar II patients 1.
Adjunctive Psychotherapy
Cognitive behavioral therapy should be offered alongside pharmacotherapy, as combination treatment is superior to either treatment alone for both depressive and anxiety components of bipolar disorder 1, 3. CBT benefits typically emerge within 6-12 sessions when combined with medication 1.
Maintenance Duration
Continue combination therapy for at least 12-24 months after achieving mood stabilization 1, 2. Some patients may require longer treatment, particularly those with multiple prior depressive episodes 1.